DAIRIN Trademark

Trademark Overview

On Tuesday, January 11, 2011, a trademark application was filed for DAIRIN with the United States Patent and Trademark Office. The USPTO has given the DAIRIN trademark a serial number of 85214734. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 4, 2014. This trademark is owned by Glaxo Group Limited. The DAIRIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
dairin

General Information

Serial Number85214734
Word MarkDAIRIN
Filing DateTuesday, January 11, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 4, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 14, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, August 4, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 4, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 14, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 13, 2014EXTENSION 5 GRANTED
Wednesday, December 11, 2013EXTENSION 5 FILED
Wednesday, December 11, 2013TEAS EXTENSION RECEIVED
Tuesday, July 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 22, 2013EXTENSION 4 GRANTED
Friday, June 21, 2013EXTENSION 4 FILED
Monday, July 22, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 21, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 12, 2012EXTENSION 3 GRANTED
Monday, December 10, 2012EXTENSION 3 FILED
Monday, December 10, 2012TEAS EXTENSION RECEIVED
Saturday, July 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 20, 2012EXTENSION 2 GRANTED
Tuesday, June 26, 2012EXTENSION 2 FILED
Friday, July 20, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 26, 2012TEAS EXTENSION RECEIVED
Tuesday, December 20, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 16, 2011EXTENSION 1 GRANTED
Friday, December 16, 2011EXTENSION 1 FILED
Friday, December 16, 2011TEAS EXTENSION RECEIVED
Tuesday, June 28, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2011PUBLISHED FOR OPPOSITION
Monday, March 28, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 28, 2011ASSIGNED TO EXAMINER
Friday, January 14, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 14, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

dairin pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological